{"id":"NCT00475215","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)","officialTitle":"A Multicenter, Randomized, Parallel Group, Comparative, Safety-Assessor Blinded, Phase IIIa Trial in Adult Surgical Subjects Under General Anesthesia at Increased Risk for Pulmonary Complications","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-10-27","primaryCompletion":"2006-08-21","completion":"2006-09-09","firstPosted":"2007-05-21","resultsPosted":"2019-04-12","lastUpdate":"2019-04-12"},"enrollment":86,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anesthesia, General"],"interventions":[{"type":"DRUG","name":"Sugammadex","otherNames":["Org 25969, MK-8616, Bridion®"]},{"type":"DRUG","name":"Rocuronium","otherNames":["Zemuron®"]}],"arms":[{"label":"Rocuronium + Sugammadex 2.0 mg/kg","type":"EXPERIMENTAL"},{"label":"Rocuronium + Sugammadex 4.0 mg/kg","type":"EXPERIMENTAL"}],"summary":"The purpose of the trial is to research the safety and to show faster recovery after administration of 2.0 mg/kg or 4.0 mg/kg sugammadex (Org 25969, MK-8616) given as a reversal agent for 0.6 mg/kg (0.15 mg/kg maintenance dose) rocuronium (Zemuron®) in participants diagnosed with or having a history of pulmonary disease. All drug administration will be via the intravenous (IV) route.","primaryOutcome":{"measure":"Time From Start of Sugammadex Administration to Recovery of T4/T1 Ratio to 0.9 in Participants With or Having a Past History of Pulmonary Disease","timeFrame":"Up to 90 minutes","effectByArm":[{"arm":"Rocuronium + Sugammadex 2.0 mg/kg","deltaMin":2.42,"sd":1.93},{"arm":"Rocuronium + Sugammadex 4.0 mg/kg","deltaMin":2.1,"sd":1.8}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22608583"],"seeAlso":["http://www.merck.com/clinical-trials/policies-perspectives.html"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":39},"commonTop":["Procedural pain","Nausea","Incision site complication","Vomiting","Post procedural nausea"]}}